Obinutuzumab With or Without Umbralisib, Lenalidomide, or Combination Chemotherapy in Treating Patients With Relapsed or Refractory Grade I-IIIa Follicular Lymphoma
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03269669 |
Recruitment Status :
Recruiting
First Posted : September 1, 2017
Last Update Posted : April 19, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Grade 1 Follicular Lymphoma Grade 2 Follicular Lymphoma Grade 3a Follicular Lymphoma Recurrent Follicular Lymphoma Refractory Follicular Lymphoma | Drug: Bendamustine Hydrochloride Drug: Cyclophosphamide Drug: Doxorubicin Hydrochloride Drug: Lenalidomide Biological: Obinutuzumab Drug: Prednisone Drug: Umbralisib Drug: Vincristine Sulfate | Phase 2 |


PRIMARY OBJECTIVE:
I. To compare the complete response rate up to 6 cycles after randomization as defined by centrally read positron emission tomography (PET)/computed tomography (CT) (integral biomarker) of 2 targeted therapeutic regimens (obinutuzumab + umbralisib [TGR-1202] or obinutuzumab + lenalidomide) with obinutuzumab + chemotherapy (cyclophosphamide, doxorubicin hydrochloride [doxorubicin], vincristine sulfate [vincristine], and prednisone [CHOP] or bendamustine hydrochloride [bendamustine]) in patients with early relapsing or refractory follicular lymphoma.
SECONDARY OBJECTIVES:
I. To validate the prognostic association of the m7-FLIPI model, demonstrating that the population of follicular lymphoma patients who respond poorly to chemoimmunotherapy are enriched for having a high-risk m7-FLIPI score, and that the score is associated with progression-free survival (integrated biomarker). (Primary translational medicine) II. To estimate the 30-month sustained complete response rate (CR30) defined by centrally read PET/CT with each of the regimens in this early relapsing or refractory follicular lymphoma population.
III. To estimate best response up to 12 cycles of therapy, progression free survival, duration of response and overall survival with each of the combinations in early relapsing or refractory follicular lymphoma.
IV. To evaluate the adverse effects of each of the regimens in early relapsing or refractory follicular lymphoma.
V. To evaluate the predictive performance of non-invasive genotyping (m7-FLIPI in circulating tumor deoxyribonucleic acid [DNA]) of plasma at study entry relative to standard tumor genotyping (m7-FLIPI) of formalin-fixed paraffin-embedded tumor tissue.
VI. To evaluate the association between the detection of active lymphoma by PET-CT and the detection of circulating tumor DNA in plasma at baseline, after 6 and 12 cycles, and at 30 months after initiation of study therapy.
OUTLINE: Patients are randomized to 1 of 3 arms.
ARM I: Patients receive obinutuzumab intravenously (IV) on day 1 and umbralisib orally (PO) daily on days 1-28. Treatment repeats every 28 days for up to 12 cycles in the absence of disease progression or unacceptable toxicity.
ARM II: Patients receive obinutuzumab IV on day 1 and lenalidomide PO on days 1-21. Treatment repeats every 28 days for up 12 cycles in the absence of disease progression or unacceptable toxicity.
ARM III:
PRIOR BENDAMUSTINE-BASED CHEMOTHERAPY: Patients receive obinutuzumab IV on day 1, cyclophosphamide IV on day 1, doxorubicin IV on day 1, vincristine IV on day 1, and prednisone PO on days 1-5. Treatment with obinutuzumab repeats every 21 or 28 days for up to 12 cycles in the absence of disease progression or unacceptable toxicity. Treatment with combination chemotherapy repeats every 21 days for 6 cycles in the absence of disease progression or unacceptable toxicity.
PRIOR CHOP CHEMOTHERAPY: Patients receive obinutuzumab IV on day 1, and bendamustine IV over 60 minutes on days 1 and 2. Treatment repeats every 28 days for up to 6 or 12 cycles (bendamustine and obinutuzumab, respectively) in the absence of disease progression or unacceptable toxicity.
After completion of study treatment, patients are followed up every 3 months for 2 years and then every 6 months for 3 years.
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 150 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Randomized Phase II Trial in Early Relapsing or Refractory Follicular Lymphoma |
Actual Study Start Date : | August 10, 2017 |
Estimated Primary Completion Date : | December 31, 2022 |
Estimated Study Completion Date : | December 31, 2022 |

Arm | Intervention/treatment |
---|---|
Experimental: Arm I (obinutuzumab, umbralisib)
Patients receive obinutuzumab IV on day 1 and umbralisib PO daily on days 1-28. Treatment repeats every 28 days for up to 12 cycles in the absence of disease progression or unacceptable toxicity.
|
Biological: Obinutuzumab
Given IV
Other Names:
Drug: Umbralisib Given PO
Other Names:
|
Experimental: Arm II (obinutuzumab, lenalidomide)
Patients receive obinutuzumab IV on day 1 and lenalidomide PO on days 1-21. Treatment repeats every 28 days for up to 12 cycles in the absence of disease progression or unacceptable toxicity.
|
Drug: Lenalidomide
Given PO
Other Names:
Biological: Obinutuzumab Given IV
Other Names:
|
Active Comparator: Arm III (obinutuzumab, combination chemotherapy)
PRIOR BENDAMUSTINE-BASED CHEMOTHERAPY: Patients receive obinutuzumab IV on day 1, cyclophosphamide IV on day 1, doxorubicin IV on day 1, vincristine IV on day 1, and prednisone PO on days 1-5. Treatment with obinutuzumab repeats every 21 or 28 days for up to 12 cycles in the absence of disease progression or unacceptable toxicity. Treatment with combination chemotherapy repeats every 21 days for up to 6 cycles in the absence of disease progression or unacceptable toxicity. PRIOR CHOP CHEMOTHERAPY: Patients receive obinutuzumab IV on day 1, and bendamustine IV over 1 hour on days 1 and 2. Treatment repeats every 28 days for up to 6 or 12 cycles (bendamustine and obinutuzumab, respectively) in the absence of disease progression or unacceptable toxicity. |
Drug: Bendamustine Hydrochloride
Given IV
Other Names:
Drug: Cyclophosphamide Given IV
Other Names:
Drug: Doxorubicin Hydrochloride Given IV
Other Names:
Biological: Obinutuzumab Given IV
Other Names:
Drug: Prednisone Given PO
Other Names:
Drug: Vincristine Sulfate Given IV
Other Names:
|
- Complete response (CR) [ Time Frame: Up to 6 cycles ]
- Sustained complete response rate (CR30) [ Time Frame: Up to 30 months ]Defined by centrally read positron emission tomography (PET)/computed tomography (CT).
- Progression-free survival (PFS) [ Time Frame: From date of registration to date of first observation of progressive disease, or death due to any cause, assessed up to 5 years ]Will be calculated using the method of Kaplan-Meier. 95% confidence for the survival estimates will be constructed using the method of Brookmeyer-Crowley. With 45 eligible patients in each arm, progression free survival at a particular time point, and the 30-month sustained response rate can be estimated to within at least +/- 15% with 95% confidence.
- Duration of response (CR, partial response [PR]) [ Time Frame: From date of first documentation of response to treatment (CR, PR) to date of first documentation of progression, or death due to any cause, assessed up to 5 years ]Will be calculated using the method of Kaplan-Meier.
- Overall survival (OS) [ Time Frame: Up to 5 years ]Will be calculated using the method of Kaplan-Meier. 95% confidence for the survival estimates will be constructed using the method of Brookmeyer-Crowley. With 45 eligible patients in each arm, OS at a particular time point, and the 30-month sustained response rate can be estimated to within at least +/- 15% with 95% confidence.
- Incidence of adverse events [ Time Frame: Up to 5 years ]Assessed by National Cancer Institute Common Terminology Criteria for Adverse Events (CTCAE) version 4.0 (version 5.0 will be utilized for serious adverse events reporting only). Toxicity rates can be estimated to within at least +/- 15% with 95% confidence.
- Non-invasive genotyping and circulating tumor deoxyribonucleic acid (DNA) assessment [ Time Frame: Up to 5 years ]Sensitivity, specificity, positive predictive value, negative predictive value, and kappa coefficient will be used to evaluate the concordance. Will evaluate the association of detection of active lymphoma by positron emission tomography-computed tomography and the detection of circulating tumor DNA in plasma at baseline, after 6 and 12 cycles, and at 30 months after initiation of study therapy. Chi-square test will be used to evaluate the association and odds ratio will be calculated
- Active lymphoma and circulating tumor DNA in plasma [ Time Frame: From baseline up to 30 months after initiation of treatment ]The Cox proportional hazards model will be used to assess the association and odds ratio will be calculated.
- m7-FLIPI model validation [ Time Frame: Up to 5 years ]The Cox proportional hazards model will be used to assess the association of the m7-FLIPI with to PFS.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Patients must have follicular lymphoma (grade I, II or IIIa) confirmed at initial diagnosis and at relapse with identifiable fludeoxyglucose F-18 (FDG) avid disease on PET/CT; patients that have involvement with large cell lymphoma are not eligible
- Patients must not have clinical evidence of central nervous system involvement by lymphoma since the proposed treatment strategies are not designed to address central nervous system (CNS) involvement adequately; if performed, any laboratory or radiographic tests performed to assess CNS involvement must be negative
- Patients must have a whole body or limited whole body PET/CT scan performed within 42 days prior to registration
- Patients must have bone marrow biopsy performed within 42 days prior to registration
- All disease must be assessed and documented on the S1608 FDG-PET/CT assessment form
-
The intent is to enroll patients with FL relapsed within 2 years of completing their first course of chemotherapy (CHOP or bendamustine based therapy) + anti-CD20 therapy. Patient is still eligible if he/she received radiation therapy or anti-CD20 therapy prior to chemoimmunotherapy or if maintenance anti-CD20 therapy was administered after chemoimmunotherapy
- Patients must have either failed to achieve a complete remission, or must have relapsed within 2 years after completing CHOP or bendamustine-containing chemoimmunotherapy (including an anti-CD20 monoclonal antibody), as measured from the last dose of CHOP or bendamustine; relapsed patients must not have received any intervening chemotherapy
- Patients must have received only 1 course of chemotherapy, containing at least 3 cycles of CHOP or bendamustine; (note that no minimum dose of bendamustine is required)
- Patients who received any anti-CD20 antibody therapy prior to CHOP or bendamustine are eligible
- Patients who additionally received any maintenance anti-CD-20 antibody therapy or consolidative radioimmunotherapy within 2 years of the last dose of the CHOP or bendamustine therapy are eligible
-
Involved field or involved site radiation is not considered a line of therapy; examples of eligible prior treatment regimens (note this list is not all inclusive):
- 1st line rituximab treatment followed years later by bendamustine rituximab x 4 cycles
- Bendamustine rituximab x 4 cycles
- 1st line rituximab treatment, 2nd line ibritumomab tiuxetan, followed by bendamustine bortezomib rituximab x 6 cycles followed by rituximab maintenance
- Bendamustine obinutuzumab x 3 cycles
- CHOP rituximab x 6 cycles followed by rituximab maintenance
- For all forms of systemic therapy, patients must have completed therapy at least 21 days prior to registration; patients must have completed any radioimmunotherapy at least 84 days prior to registration; patients must have recovered from all treatment related toxicities from these therapies prior to registration
- Patients must not have any prior treatment with any PI3K inhibitor, or lenalidomide
- Patients must have tissue specimens collected prior to registration; patients must be offered participation in biobanking of residual specimens; with patient consent, residuals from the mandatory submission will be banked for future research
- All patients must have a Zubrod performance status of 0, 1 or 2
- Absolute neutrophil count (ANC) >= 1,500/mcL within 28 days prior to registration
- Platelets >= 75,000/mcL within 28 days prior to registration
- Patients must have adequate renal function as documented by a calculated creatinine clearance >= 60 mL/min, within 28 days prior to registration
- Total bilirubin =< 1.5 x institutional upper limit of normal (IULN) (=< 5 x IULN if secondary to lymphoma, Gilbert's syndrome, or medication related [e.g., indinavir, tenofovir, atazanavir]) within 28 days prior to registration
- Direct bilirubin =< 1.5 x IULN (=< 5 x IULN if secondary to lymphoma) within 28 days prior to registration
- Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) =< 2.5 x IULN (=< 5 x IULN secondary to lymphoma) within 28 days prior to registration
- Patients must have an echocardiogram (ECHO) or multigated acquisition (MUGA) scan within 42 days prior to registration with a cardiac ejection fraction >= 45%
-
Patients with hepatitis B virus infection must have undetectable hepatitis B virus (HBV) on suppressive therapy and no evidence of HBV-related hepatic damage; patients with hepatitis C virus infection are eligible if complete eradication therapy has been successfully completed, and there is no detectable hepatitis C virus (HVC) or related hepatic damage; patients with known human immunodeficiency virus (HIV) infection are eligible if they meet all of the following criteria in addition to the other protocol eligibility criteria:
- Patient must have no history of acquired immune deficiency syndrome (AIDS)-related complications, other than a history of low CD4+ T-cell count (< 200/mm^3) prior to initiation of combination antiretroviral therapy; on study CD4+ T-cell count may not be informative due to leukemia and should not be used as an exclusion criterion if low
- Patient must be healthy on the basis of HIV disease with high likelihood of near normal life span were it not for the leukemia
- Patient must have serum HIV viral load of < 200 copies/mm^3
- Patient must be on combination antiretroviral therapy with minimal pharmacokinetic interactions with study therapy and minimal overlapping clinical toxicity with protocol therapy; (recommend a regimen of the integrase inhibitor dolutegravir combined with either disoproxil fumarate/emtricitabine or dolutegravir combined with tenofovir alafenamide/emtricitabine)
- Protease inhibitors and once daily formulations containing cobicistat are NOT allowed due to potential pharmacokinetic interactions with leukemia therapy
- Stavudine and zidovudine (AZT) are NOT allowed because of overlapping toxicity with protocol therapy
- Patients must be able and willing to receive prophylaxis with daily aspirin, low molecular weight heparin, factor X inhibitors or warfarin if randomized to lenalidomide; patients must also be willing to receive pneumocystis jirovecii prophylaxis with sulfamethoxazole/trimethoprim, dapsone, atovaquone or inhaled pentamidine, in the event that they are randomized to TGR-1202; patients unable or unwilling to take any listed prophylaxis are NOT eligible
- Patients must be able to discontinue CYP2C9 substrates with a narrow therapeutic index (e.g. warfarin, phenytoin), if randomized to TGR-1202; patients must discontinue such agents at least 1 week or 5 half-lives prior to beginning protocol therapy (whichever is longer)
- No second prior malignancy is allowed except for adequately treated basal (or squamous cell) skin cancer, in situ cervical cancer or other cancer for which the patient has been disease free for three years
- Patients must have a complete history and physical examination within 28 days prior to registration
- Females of childbearing potential (FCBP) must have a negative serum or urine pregnancy test with a sensitivity of at least 25 mIU/mL within 10-14 days and again within 24 hours prior to starting cycle 1 of lenalidomide; further, they must either commit to complete abstinence (true abstinence is acceptable when this is in line with the preferred and usual lifestyle of the subject; periodic abstinence [e.g., calendar, ovulation, symptothermal or post ovulation methods] and withdrawal are not acceptable methods of contraception) from heterosexual intercourse or begin TWO acceptable methods of birth control: one highly effective method and one additional effective method AT THE SAME TIME, at least 28 days before starting lenalidomide; while taking lenalidomide, during dose interruptions, and for at least 28 days after the last dose of lenalidomide; FCBP must also agree to ongoing pregnancy testing; men must agree to use a latex condom during sexual contact with a FCBP, even if they have had a successful vasectomy; a FCBP is a female who: 1) has achieve menarche at some point; 2) has not undergone a hysterectomy or bilateral oophorectomy; or 3) has not been naturally postmenopausal (amenorrhea following cancer therapy does not rule out childbearing potential) for at least 24 consecutive months (i.e., has had menses at any time in the preceding 24 consecutive months); all patients must be counseled by a trained counselor every 28 days about pregnancy precautions and risks of fetal exposure; NOTE: patients not randomized to receive lenalidomide will not be required to undergo serial pregnancy testing or lenalidomide counseling after registration
- Patients must have lactate dehydrogenase (LDH) and beta-2-microglobulin collected within 28 days prior to registration
- Patients must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines
- As a part of the Oncology Patient Enrollment Network (OPEN) registration process the treating institution's identity is provided in order to ensure that the current (within 365 days) date of institutional review board approval for this study has been entered in the system

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03269669


United States, Alaska | |
Alaska Breast Care and Surgery LLC | Recruiting |
Anchorage, Alaska, United States, 99508 | |
Contact: Site Public Contact 907-212-6871 AKPAMC.OncologyResearchSupport@providence.org | |
Principal Investigator: Gary E. Goodman | |
Alaska Oncology and Hematology LLC | Recruiting |
Anchorage, Alaska, United States, 99508 | |
Contact: Site Public Contact 907-212-6871 AKPAMC.OncologyResearchSupport@providence.org | |
Principal Investigator: Gary E. Goodman | |
Alaska Women's Cancer Care | Recruiting |
Anchorage, Alaska, United States, 99508 | |
Contact: Site Public Contact 907-212-6871 AKPAMC.OncologyResearchSupport@providence.org | |
Principal Investigator: Gary E. Goodman | |
Anchorage Oncology Centre | Recruiting |
Anchorage, Alaska, United States, 99508 | |
Contact: Site Public Contact 907-212-6871 AKPAMC.OncologyResearchSupport@providence.org | |
Principal Investigator: Gary E. Goodman | |
Katmai Oncology Group | Recruiting |
Anchorage, Alaska, United States, 99508 | |
Contact: Site Public Contact 907-212-6871 AKPAMC.OncologyResearchSupport@providence.org | |
Principal Investigator: Gary E. Goodman | |
Providence Alaska Medical Center | Recruiting |
Anchorage, Alaska, United States, 99508 | |
Contact: Site Public Contact 907-212-6871 AKPAMC.OncologyResearchSupport@providence.org | |
Principal Investigator: Gary E. Goodman | |
United States, Arizona | |
Banner University Medical Center - Tucson | Recruiting |
Tucson, Arizona, United States, 85719 | |
Contact: Site Public Contact aselegue@email.arizona.edu | |
Principal Investigator: Daniel O. Persky | |
University of Arizona Cancer Center-North Campus | Recruiting |
Tucson, Arizona, United States, 85719 | |
Contact: Site Public Contact 800-327-2873 | |
Principal Investigator: Daniel O. Persky | |
United States, California | |
Kaiser Permanente-Anaheim | Recruiting |
Anaheim, California, United States, 92806 | |
Contact: Site Public Contact 800-398-3996 clinical.trials@kp.org | |
Principal Investigator: Ashraf R. Aziz | |
Kaiser Permanente-Deer Valley Medical Center | Recruiting |
Antioch, California, United States, 94531 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Tatjana Kolevska | |
PCR Oncology | Recruiting |
Arroyo Grande, California, United States, 93420 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Sutter Auburn Faith Hospital | Active, not recruiting |
Auburn, California, United States, 95602 | |
Kaiser Permanente-Baldwin Park | Recruiting |
Baldwin Park, California, United States, 91706 | |
Contact: Site Public Contact 800-398-3996 clinical.trials@kp.org | |
Principal Investigator: Ashraf R. Aziz | |
Kaiser Permanente-Bellflower | Recruiting |
Bellflower, California, United States, 90706 | |
Contact: Site Public Contact 800-398-3996 clinical.trials@kp.org | |
Principal Investigator: Ashraf R. Aziz | |
Alta Bates Summit Medical Center-Herrick Campus | Active, not recruiting |
Berkeley, California, United States, 94704 | |
Providence Saint Joseph Medical Center/Disney Family Cancer Center | Recruiting |
Burbank, California, United States, 91505 | |
Contact: Site Public Contact 818-847-4793 Najee.Boucher@providence.org | |
Principal Investigator: Gary E. Goodman | |
City of Hope Comprehensive Cancer Center | Recruiting |
Duarte, California, United States, 91010 | |
Contact: Site Public Contact 800-826-4673 becomingapatient@coh.org | |
Principal Investigator: Alex F. Herrera | |
Kaiser Permanente Dublin | Recruiting |
Dublin, California, United States, 94568 | |
Contact: Site Public Contact 877-642-4691 | |
Principal Investigator: Tatjana Kolevska | |
Kaiser Permanente-Fontana | Recruiting |
Fontana, California, United States, 92335 | |
Contact: Site Public Contact 800-398-3996 clinical.trials@kp.org | |
Principal Investigator: Ashraf R. Aziz | |
Kaiser Permanente-Fremont | Recruiting |
Fremont, California, United States, 94538 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Tatjana Kolevska | |
Kaiser Permanente-Fresno | Recruiting |
Fresno, California, United States, 93720 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Tatjana Kolevska | |
Kaiser Permanente - Harbor City | Recruiting |
Harbor City, California, United States, 90710 | |
Contact: Site Public Contact 800-398-3996 clinical.trials@kp.org | |
Principal Investigator: Ashraf R. Aziz | |
Kaiser Permanente-Irvine | Recruiting |
Irvine, California, United States, 92618 | |
Contact: Site Public Contact 800-398-3996 clinical.trials@kp.org | |
Principal Investigator: Ashraf R. Aziz | |
Loma Linda University Medical Center | Suspended |
Loma Linda, California, United States, 92354 | |
Kaiser Permanente Los Angeles Medical Center | Recruiting |
Los Angeles, California, United States, 90027 | |
Contact: Site Public Contact 800-398-3996 clinical.trials@kp.org | |
Principal Investigator: Ashraf R. Aziz | |
Kaiser Permanente West Los Angeles | Recruiting |
Los Angeles, California, United States, 90034 | |
Contact: Site Public Contact 800-398-3996 clinical.trials@kp.org | |
Principal Investigator: Ashraf R. Aziz | |
Memorial Medical Center | Active, not recruiting |
Modesto, California, United States, 95355 | |
Kaiser Permanente-Modesto | Recruiting |
Modesto, California, United States, 95356 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Tatjana Kolevska | |
Palo Alto Medical Foundation-Camino Division | Active, not recruiting |
Mountain View, California, United States, 94040 | |
Palo Alto Medical Foundation-Gynecologic Oncology | Active, not recruiting |
Mountain View, California, United States, 94040 | |
Kaiser Permanente Oakland-Broadway | Recruiting |
Oakland, California, United States, 94611 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Tatjana Kolevska | |
Kaiser Permanente-Oakland | Recruiting |
Oakland, California, United States, 94611 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Tatjana Kolevska | |
Kaiser Permanente-Ontario | Recruiting |
Ontario, California, United States, 91761 | |
Contact: Site Public Contact 800-398-3996 clinical.trials@kp.org | |
Principal Investigator: Ashraf R. Aziz | |
Palo Alto Medical Foundation Health Care | Active, not recruiting |
Palo Alto, California, United States, 94301 | |
VA Palo Alto Health Care System | Recruiting |
Palo Alto, California, United States, 94304 | |
Contact: Site Public Contact 800-455-0057 | |
Principal Investigator: Allyson C. Spence | |
Kaiser Permanente - Panorama City | Recruiting |
Panorama City, California, United States, 91402 | |
Contact: Site Public Contact 800-398-3996 clinical.trials@kp.org | |
Principal Investigator: Ashraf R. Aziz | |
Eisenhower Medical Center | Active, not recruiting |
Rancho Mirage, California, United States, 92270 | |
Kaiser Permanente-Richmond | Recruiting |
Richmond, California, United States, 94801 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Tatjana Kolevska | |
Kaiser Permanente-Roseville | Recruiting |
Roseville, California, United States, 95661 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Tatjana Kolevska | |
Kaiser Permanente Downtown Commons | Recruiting |
Sacramento, California, United States, 95814 | |
Contact: Site Public Contact 877-642-4691 kpoct@kp.org | |
Principal Investigator: Tatjana Kolevska | |
Sutter Medical Center Sacramento | Active, not recruiting |
Sacramento, California, United States, 95816 | |
Kaiser Permanente-South Sacramento | Recruiting |
Sacramento, California, United States, 95823 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Tatjana Kolevska | |
Kaiser Permanente - Sacramento | Recruiting |
Sacramento, California, United States, 95825 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Tatjana Kolevska | |
Kaiser Permanente-San Diego Mission | Recruiting |
San Diego, California, United States, 92108 | |
Contact: Site Public Contact 800-398-3996 clinical.trials@kp.org | |
Principal Investigator: Ashraf R. Aziz | |
Kaiser Permanente-San Diego Zion | Recruiting |
San Diego, California, United States, 92120 | |
Contact: Site Public Contact 800-398-3996 clinical.trials@kp.org | |
Principal Investigator: Ashraf R. Aziz | |
California Pacific Medical Center-Pacific Campus | Active, not recruiting |
San Francisco, California, United States, 94115 | |
Kaiser Permanente-San Francisco | Recruiting |
San Francisco, California, United States, 94115 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Tatjana Kolevska | |
Kaiser Permanente-Santa Teresa-San Jose | Recruiting |
San Jose, California, United States, 95119 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Tatjana Kolevska | |
Kaiser Permanente San Leandro | Recruiting |
San Leandro, California, United States, 94577 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Tatjana Kolevska | |
Kaiser Permanente-San Marcos | Recruiting |
San Marcos, California, United States, 92078 | |
Contact: Site Public Contact 800-398-3996 clinical.trials@kp.org | |
Principal Investigator: Ashraf R. Aziz | |
Kaiser Permanente-San Rafael | Recruiting |
San Rafael, California, United States, 94903 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Tatjana Kolevska | |
Kaiser San Rafael-Gallinas | Recruiting |
San Rafael, California, United States, 94903 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Tatjana Kolevska | |
Kaiser Permanente Medical Center - Santa Clara | Recruiting |
Santa Clara, California, United States, 95051 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Tatjana Kolevska | |
Palo Alto Medical Foundation-Santa Cruz | Active, not recruiting |
Santa Cruz, California, United States, 95065 | |
Kaiser Permanente-Santa Rosa | Recruiting |
Santa Rosa, California, United States, 95403 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Tatjana Kolevska | |
Sutter Pacific Medical Foundation | Active, not recruiting |
Santa Rosa, California, United States, 95403 | |
Kaiser Permanente-South San Francisco | Recruiting |
South San Francisco, California, United States, 94080 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Tatjana Kolevska | |
Kaiser Permanente-Stockton | Recruiting |
Stockton, California, United States, 95210 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Tatjana Kolevska | |
Palo Alto Medical Foundation-Sunnyvale | Active, not recruiting |
Sunnyvale, California, United States, 94086 | |
Kaiser Permanente Medical Center-Vacaville | Recruiting |
Vacaville, California, United States, 95688 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Tatjana Kolevska | |
Kaiser Permanente-Vallejo | Recruiting |
Vallejo, California, United States, 94589 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Tatjana Kolevska | |
Kaiser Permanente-Walnut Creek | Recruiting |
Walnut Creek, California, United States, 94596 | |
Contact: Site Public Contact 877-642-4691 Kpoct@kp.org | |
Principal Investigator: Tatjana Kolevska | |
Kaiser Permanente-Woodland Hills | Recruiting |
Woodland Hills, California, United States, 91367 | |
Contact: Site Public Contact 800-398-3996 clinical.trials@kp.org | |
Principal Investigator: Ashraf R. Aziz | |
United States, Colorado | |
Rocky Mountain Cancer Centers-Aurora | Recruiting |
Aurora, Colorado, United States, 80012 | |
Contact: Site Public Contact 303-777-2663 info@westernstatesncorp.org | |
Principal Investigator: Nicholas DiBella | |
The Medical Center of Aurora | Recruiting |
Aurora, Colorado, United States, 80012 | |
Contact: Site Public Contact 303-777-2663 info@westernstatesncorp.org | |
Principal Investigator: Nicholas DiBella | |
Boulder Community Hospital | Recruiting |
Boulder, Colorado, United States, 80301 | |
Contact: Site Public Contact 303-777-2663 jbloomfield@co-cancerresearch.org | |
Principal Investigator: Nicholas DiBella | |
Rocky Mountain Cancer Centers-Boulder | Recruiting |
Boulder, Colorado, United States, 80304 | |
Contact: Site Public Contact 303-777-2663 info@westernstatesncorp.org | |
Principal Investigator: Nicholas DiBella | |
Penrose-Saint Francis Healthcare | Recruiting |
Colorado Springs, Colorado, United States, 80907 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Rocky Mountain Cancer Centers-Penrose | Recruiting |
Colorado Springs, Colorado, United States, 80907 | |
Contact: Site Public Contact 303-777-2663 info@westernstatesncorp.org | |
Principal Investigator: Richard L. Deming | |
Denver Health Medical Center | Suspended |
Denver, Colorado, United States, 80204 | |
Porter Adventist Hospital | Recruiting |
Denver, Colorado, United States, 80210 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Colorado Blood Cancer Institute | Recruiting |
Denver, Colorado, United States, 80218 | |
Contact: Site Public Contact 303-777-2663 info@westernstatesncorp.org | |
Principal Investigator: Nicholas DiBella | |
Presbyterian - Saint Lukes Medical Center - Health One | Recruiting |
Denver, Colorado, United States, 80218 | |
Contact: Site Public Contact 303-777-2663 info@westernstatesncorp.org | |
Principal Investigator: Nicholas DiBella | |
Rocky Mountain Cancer Centers-Midtown | Recruiting |
Denver, Colorado, United States, 80218 | |
Contact: Site Public Contact 303-777-2663 info@westernstatesncorp.org | |
Principal Investigator: Nicholas DiBella | |
SCL Health Saint Joseph Hospital | Suspended |
Denver, Colorado, United States, 80218 | |
Rocky Mountain Cancer Centers-Rose | Recruiting |
Denver, Colorado, United States, 80220 | |
Contact: Site Public Contact 303-777-2663 info@westernstatesncorp.org | |
Principal Investigator: Nicholas DiBella | |
Rose Medical Center | Suspended |
Denver, Colorado, United States, 80220 | |
Mercy Medical Center | Recruiting |
Durango, Colorado, United States, 81301 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Mountain Blue Cancer Care Center - Swedish | Recruiting |
Englewood, Colorado, United States, 80113 | |
Contact: Site Public Contact 303-777-2663 info@westernstatesncorp.org | |
Principal Investigator: Nicholas DiBella | |
Swedish Medical Center | Recruiting |
Englewood, Colorado, United States, 80113 | |
Contact: Site Public Contact 303-777-2663 info@westernstatesncorp.org | |
Principal Investigator: Nicholas DiBella | |
Mountain Blue Cancer Care Center | Suspended |
Golden, Colorado, United States, 80401 | |
Saint Mary's Hospital and Regional Medical Center | Suspended |
Grand Junction, Colorado, United States, 81501 | |
North Colorado Medical Center | Recruiting |
Greeley, Colorado, United States, 80631 | |
Contact: Site Public Contact 303-777-2663 info@westernstatesncorp.org | |
Principal Investigator: Nicholas DiBella | |
Rocky Mountain Cancer Centers-Greenwood Village | Suspended |
Greenwood Village, Colorado, United States, 80111 | |
Rocky Mountain Cancer Centers-Lakewood | Suspended |
Lakewood, Colorado, United States, 80228 | |
Saint Anthony Hospital | Recruiting |
Lakewood, Colorado, United States, 80228 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Rocky Mountain Cancer Centers-Littleton | Recruiting |
Littleton, Colorado, United States, 80120 | |
Contact: Site Public Contact 303-777-2663 info@westernstatesncorp.org | |
Principal Investigator: Nicholas DiBella | |
Littleton Adventist Hospital | Recruiting |
Littleton, Colorado, United States, 80122 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Rocky Mountain Cancer Centers-Sky Ridge | Recruiting |
Lone Tree, Colorado, United States, 80124 | |
Contact: Site Public Contact 303-777-2663 info@westernstatesncorp.org | |
Principal Investigator: Nicholas DiBella | |
Sky Ridge Medical Center | Recruiting |
Lone Tree, Colorado, United States, 80124 | |
Contact: Site Public Contact 303-777-2663 info@westernstatesncorp.org | |
Principal Investigator: Nicholas DiBella | |
Longmont United Hospital | Recruiting |
Longmont, Colorado, United States, 80501 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Rocky Mountain Cancer Centers-Longmont | Recruiting |
Longmont, Colorado, United States, 80501 | |
Contact: Site Public Contact 303-777-2663 info@westernstatesncorp.org | |
Principal Investigator: Richard L. Deming | |
McKee Medical Center | Recruiting |
Loveland, Colorado, United States, 80539 | |
Contact: Site Public Contact 303-777-2663 info@westernstatesncorp.org | |
Principal Investigator: Nicholas DiBella | |
Parker Adventist Hospital | Recruiting |
Parker, Colorado, United States, 80138 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Rocky Mountain Cancer Centers-Parker | Suspended |
Parker, Colorado, United States, 80138 | |
Saint Mary Corwin Medical Center | Recruiting |
Pueblo, Colorado, United States, 81004 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Rocky Mountain Cancer Centers-Thornton | Suspended |
Thornton, Colorado, United States, 80260 | |
SCL Health Lutheran Medical Center | Suspended |
Wheat Ridge, Colorado, United States, 80033 | |
United States, Connecticut | |
Smilow Cancer Hospital Care Center at Saint Francis | Active, not recruiting |
Hartford, Connecticut, United States, 06105 | |
Smilow Cancer Center/Yale-New Haven Hospital | Active, not recruiting |
New Haven, Connecticut, United States, 06510 | |
Yale University | Active, not recruiting |
New Haven, Connecticut, United States, 06520 | |
Yale-New Haven Hospital North Haven Medical Center | Active, not recruiting |
North Haven, Connecticut, United States, 06473 | |
United States, Florida | |
University of Florida Health Science Center - Gainesville | Active, not recruiting |
Gainesville, Florida, United States, 32610 | |
Baptist MD Anderson Cancer Center | Recruiting |
Jacksonville, Florida, United States, 32207 | |
Contact: Site Public Contact 904-202-7468 | |
Principal Investigator: William A. Hammond | |
United States, Georgia | |
Emory University Hospital/Winship Cancer Institute | Recruiting |
Atlanta, Georgia, United States, 30322 | |
Contact: Site Public Contact 404-778-1868 | |
Principal Investigator: Kristie A. Blum | |
Lewis Cancer and Research Pavilion at Saint Joseph's/Candler | Recruiting |
Savannah, Georgia, United States, 31405 | |
Contact: Site Public Contact 912-819-5704 underberga@sjchs.org | |
Principal Investigator: Howard A. Zaren | |
United States, Hawaii | |
Kaiser Permanente Moanalua Medical Center | Recruiting |
Honolulu, Hawaii, United States, 96819 | |
Contact: Site Public Contact 808-432-5195 shelley.a.clark@kp.org | |
Principal Investigator: Tatjana Kolevska | |
United States, Idaho | |
Saint Alphonsus Cancer Care Center-Boise | Recruiting |
Boise, Idaho, United States, 83706 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: John M. Schallenkamp | |
Saint Luke's Cancer Institute - Boise | Recruiting |
Boise, Idaho, United States, 83712 | |
Contact: Site Public Contact 208-381-2774 eslinget@slhs.org | |
Principal Investigator: Gary E. Goodman | |
Saint Luke's Cancer Institute - Fruitland | Recruiting |
Fruitland, Idaho, United States, 83619 | |
Contact: Site Public Contact 208-381-2774 eslinget@slhs.org | |
Principal Investigator: Gary E. Goodman | |
Saint Luke's Cancer Institute - Meridian | Recruiting |
Meridian, Idaho, United States, 83642 | |
Contact: Site Public Contact 208-381-2774 eslinget@slhs.org | |
Principal Investigator: Gary E. Goodman | |
Saint Luke's Cancer Institute - Nampa | Recruiting |
Nampa, Idaho, United States, 83686 | |
Contact: Site Public Contact 208-381-2774 eslinget@slhs.org | |
Principal Investigator: Gary E. Goodman | |
Kootenai Cancer Center | Recruiting |
Post Falls, Idaho, United States, 83854 | |
Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
Principal Investigator: John M. Schallenkamp | |
Saint Luke's Cancer Institute - Twin Falls | Recruiting |
Twin Falls, Idaho, United States, 83301 | |
Contact: Site Public Contact 208-381-2774 eslinget@slhs.org | |
Principal Investigator: Gary E. Goodman | |
United States, Illinois | |
Illinois CancerCare-Bloomington | Recruiting |
Bloomington, Illinois, United States, 61704 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Illinois CancerCare-Canton | Recruiting |
Canton, Illinois, United States, 61520 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Illinois CancerCare-Carthage | Recruiting |
Carthage, Illinois, United States, 62321 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Northwestern University | Recruiting |
Chicago, Illinois, United States, 60611 | |
Contact: Site Public Contact 312-695-1301 cancer@northwestern.edu | |
Principal Investigator: Jane N. Winter | |
Rush University Medical Center | Recruiting |
Chicago, Illinois, United States, 60612 | |
Contact: Site Public Contact 312-942-5498 clinical_trials@rush.edu | |
Principal Investigator: Parameswaran Venugopal | |
University of Chicago Comprehensive Cancer Center | Recruiting |
Chicago, Illinois, United States, 60637 | |
Contact: Site Public Contact 773-702-8222 cancerclinicaltrials@bsd.uchicago.edu | |
Principal Investigator: Sonali M. Smith | |
Carle on Vermilion | Recruiting |
Danville, Illinois, United States, 61832 | |
Contact: Site Public Contact 800-446-5532 Research@carle.com | |
Principal Investigator: Priyank P. Patel | |
Cancer Care Specialists of Illinois - Decatur | Recruiting |
Decatur, Illinois, United States, 62526 | |
Contact: Site Public Contact 217-876-4740 rhamrick@dmhhs.org | |
Principal Investigator: Bryan A. Faller | |
Decatur Memorial Hospital | Recruiting |
Decatur, Illinois, United States, 62526 | |
Contact: Site Public Contact 217-876-4740 rhamrick@dmhhs.org | |
Principal Investigator: Bryan A. Faller | |
Carle Physician Group-Effingham | Recruiting |
Effingham, Illinois, United States, 62401 | |
Contact: Site Public Contact 800-446-5532 Research@carle.com | |
Principal Investigator: Priyank P. Patel | |
Crossroads Cancer Center | Recruiting |
Effingham, Illinois, United States, 62401 | |
Contact: Site Public Contact 217-876-4740 rhamrick@dmhhs.org | |
Principal Investigator: Bryan A. Faller | |
Illinois CancerCare-Eureka | Recruiting |
Eureka, Illinois, United States, 61530 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Illinois CancerCare-Galesburg | Recruiting |
Galesburg, Illinois, United States, 61401 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Northwestern Medicine Cancer Center Delnor | Recruiting |
Geneva, Illinois, United States, 60134 | |
Contact: Site Public Contact 630-352-5360 Donald.Smith3@nm.org | |
Principal Investigator: Robert M. Eisner | |
Illinois CancerCare-Kewanee Clinic | Recruiting |
Kewanee, Illinois, United States, 61443 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Northwestern Medicine Lake Forest Hospital | Recruiting |
Lake Forest, Illinois, United States, 60045 | |
Contact: Site Public Contact cancertrials@northwestern.edu | |
Principal Investigator: Jane N. Winter | |
Illinois CancerCare-Macomb | Recruiting |
Macomb, Illinois, United States, 61455 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Carle Physician Group-Mattoon/Charleston | Recruiting |
Mattoon, Illinois, United States, 61938 | |
Contact: Site Public Contact 800-446-5532 Research@carle.com | |
Principal Investigator: Priyank P. Patel | |
Loyola University Medical Center | Suspended |
Maywood, Illinois, United States, 60153 | |
Cancer Care Center of O'Fallon | Recruiting |
O'Fallon, Illinois, United States, 62269 | |
Contact: Site Public Contact 217-876-4762 morganthaler.jodi@mhsil.com | |
Principal Investigator: Bryan A. Faller | |
Illinois CancerCare-Ottawa Clinic | Recruiting |
Ottawa, Illinois, United States, 61350 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Illinois CancerCare-Pekin | Recruiting |
Pekin, Illinois, United States, 61554 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Illinois CancerCare-Peoria | Recruiting |
Peoria, Illinois, United States, 61615 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Illinois CancerCare-Peru | Recruiting |
Peru, Illinois, United States, 61354 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Illinois CancerCare-Princeton | Recruiting |
Princeton, Illinois, United States, 61356 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
SwedishAmerican Regional Cancer Center/ACT | Recruiting |
Rockford, Illinois, United States, 61114 | |
Contact: Site Public Contact 779-696-9400 cancercare@swedishamerican.org | |
Principal Investigator: Harvey E. Einhorn | |
Southern Illinois University School of Medicine | Recruiting |
Springfield, Illinois, United States, 62702 | |
Contact: Site Public Contact 217-545-7929 | |
Principal Investigator: Bryan A. Faller | |
Springfield Clinic | Recruiting |
Springfield, Illinois, United States, 62702 | |
Contact: Site Public Contact 800-444-7541 | |
Principal Investigator: Bryan A. Faller | |
Memorial Medical Center | Recruiting |
Springfield, Illinois, United States, 62781 | |
Contact: Site Public Contact 217-788-3528 | |
Principal Investigator: Bryan A. Faller | |
Carle Cancer Center | Recruiting |
Urbana, Illinois, United States, 61801 | |
Contact: Site Public Contact 800-446-5532 Research@carle.com | |
Principal Investigator: Priyank P. Patel | |
The Carle Foundation Hospital | Recruiting |
Urbana, Illinois, United States, 61801 | |
Contact: Site Public Contact 800-446-5532 Research@carle.com | |
Principal Investigator: Priyank P. Patel | |
Northwestern Medicine Cancer Center Warrenville | Recruiting |
Warrenville, Illinois, United States, 60555 | |
Contact: Site Public Contact 630-352-5360 Donald.Smith3@nm.org | |
Principal Investigator: Robert M. Eisner | |
United States, Indiana | |
Parkview Hospital Randallia | Active, not recruiting |
Fort Wayne, Indiana, United States, 46805 | |
Parkview Regional Medical Center | Recruiting |
Fort Wayne, Indiana, United States, 46845 | |
Contact: Site Public Contact 877-784-4673 | |
Principal Investigator: Jeffrey P. Letzer | |
Reid Health | Recruiting |
Richmond, Indiana, United States, 47374 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
United States, Iowa | |
Medical Oncology and Hematology Associates-West Des Moines | Recruiting |
Clive, Iowa, United States, 50325 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Mercy Cancer Center-West Lakes | Recruiting |
Clive, Iowa, United States, 50325 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Iowa Methodist Medical Center | Recruiting |
Des Moines, Iowa, United States, 50309 | |
Contact: Site Public Contact 515-241-6727 | |
Principal Investigator: Robert J. Behrens | |
Medical Oncology and Hematology Associates-Des Moines | Recruiting |
Des Moines, Iowa, United States, 50309 | |
Contact: Site Public Contact 515-282-2921 | |
Principal Investigator: Robert J. Behrens | |
Broadlawns Medical Center | Recruiting |
Des Moines, Iowa, United States, 50314 | |
Contact: Site Public Contact 515-282-2200 | |
Principal Investigator: Robert J. Behrens | |
Medical Oncology and Hematology Associates-Laurel | Recruiting |
Des Moines, Iowa, United States, 50314 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Mercy Medical Center - Des Moines | Recruiting |
Des Moines, Iowa, United States, 50314 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Iowa Lutheran Hospital | Recruiting |
Des Moines, Iowa, United States, 50316 | |
Contact: Site Public Contact 515-241-8704 | |
Principal Investigator: Robert J. Behrens | |
Trinity Regional Medical Center | Recruiting |
Fort Dodge, Iowa, United States, 50501 | |
Contact: Site Public Contact 515-574-8302 | |
Principal Investigator: Robert J. Behrens | |
University of Iowa/Holden Comprehensive Cancer Center | Recruiting |
Iowa City, Iowa, United States, 52242 | |
Contact: Site Public Contact 800-237-1225 | |
Principal Investigator: Brian K. Link | |
Siouxland Regional Cancer Center | Recruiting |
Sioux City, Iowa, United States, 51101 | |
Contact: Site Public Contact 712-252-9326 HoopingarnerT@jencc.com | |
Principal Investigator: Donald B. Wender | |
Methodist West Hospital | Recruiting |
West Des Moines, Iowa, United States, 50266-7700 | |
Contact: Site Public Contact 515-343-1000 | |
Principal Investigator: Robert J. Behrens | |
Mercy Medical Center-West Lakes | Recruiting |
West Des Moines, Iowa, United States, 50266 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
United States, Kansas | |
Cancer Center of Kansas - Chanute | Recruiting |
Chanute, Kansas, United States, 66720 | |
Contact: Site Public Contact 316-268-5374 Keisha.humphries@ascension.org | |
Principal Investigator: Shaker R. Dakhil | |
Cancer Center of Kansas - Dodge City | Recruiting |
Dodge City, Kansas, United States, 67801 | |
Contact: Site Public Contact 316-268-5374 Keisha.humphries@ascension.org | |
Principal Investigator: Shaker R. Dakhil | |
Cancer Center of Kansas - El Dorado | Recruiting |
El Dorado, Kansas, United States, 67042 | |
Contact: Site Public Contact 316-268-5374 Keisha.humphries@ascension.org | |
Principal Investigator: Shaker R. Dakhil | |
Central Care Cancer Center - Great Bend | Suspended |
Great Bend, Kansas, United States, 67530 | |
Cancer Center of Kansas-Independence | Recruiting |
Independence, Kansas, United States, 67301 | |
Contact: Site Public Contact 316-268-5374 Keisha.humphries@ascension.org | |
Principal Investigator: Shaker R. Dakhil | |
Cancer Center of Kansas-Kingman | Recruiting |
Kingman, Kansas, United States, 67068 | |
Contact: Site Public Contact 316-268-5374 Keisha.humphries@ascension.org | |
Principal Investigator: Shaker R. Dakhil | |
Lawrence Memorial Hospital | Suspended |
Lawrence, Kansas, United States, 66044 | |
Cancer Center of Kansas-Liberal | Recruiting |
Liberal, Kansas, United States, 67905 | |
Contact: Site Public Contact 316-268-5374 Keisha.humphries@ascension.org | |
Principal Investigator: Shaker R. Dakhil | |
Cancer Center of Kansas-Manhattan | Recruiting |
Manhattan, Kansas, United States, 66502 | |
Contact: Site Public Contact 316-268-5784 Keisha.humphries@ascension.org | |
Principal Investigator: Shaker R. Dakhil | |
Cancer Center of Kansas - McPherson | Recruiting |
McPherson, Kansas, United States, 67460 | |
Contact: Site Public Contact 316-268-5374 Keisha.humphries@ascension.org | |
Principal Investigator: Shaker R. Dakhil | |
Cancer Center of Kansas - Newton | Recruiting |
Newton, Kansas, United States, 67114 | |
Contact: Site Public Contact 316-268-5374 Keisha.humphries@ascension.org | |
Principal Investigator: Shaker R. Dakhil | |
Cancer Center of Kansas - Parsons | Recruiting |
Parsons, Kansas, United States, 67357 | |
Contact: Site Public Contact 316-268-5374 Keisha.humphries@ascension.org | |
Principal Investigator: Shaker R. Dakhil | |
Cancer Center of Kansas - Pratt | Recruiting |
Pratt, Kansas, United States, 67124 | |
Contact: Site Public Contact 316-268-5374 Keisha.humphries@ascension.org | |
Principal Investigator: Shaker R. Dakhil | |
Cancer Center of Kansas - Salina | Recruiting |
Salina, Kansas, United States, 67401 | |
Contact: Site Public Contact 316-268-5374 Keisha.humphries@ascension.org | |
Principal Investigator: Shaker R. Dakhil | |
Cancer Center of Kansas - Wellington | Recruiting |
Wellington, Kansas, United States, 67152 | |
Contact: Site Public Contact 316-268-5374 Keisha.humphries@ascension.org | |
Principal Investigator: Shaker R. Dakhil | |
Cancer Center of Kansas-Wichita Medical Arts Tower | Recruiting |
Wichita, Kansas, United States, 67208 | |
Contact: Site Public Contact 316-268-5374 Keisha.humphries@ascension.org | |
Principal Investigator: Shaker R. Dakhil | |
Cancer Center of Kansas - Wichita | Recruiting |
Wichita, Kansas, United States, 67214 | |
Contact: Site Public Contact 316-268-5374 Keisha.humphries@ascension.org | |
Principal Investigator: Shaker R. Dakhil | |
Wesley Medical Center | Recruiting |
Wichita, Kansas, United States, 67214 | |
Contact: Site Public Contact 316-268-5374 Keisha.humphries@ascension.org | |
Principal Investigator: Shaker R. Dakhil | |
Cancer Center of Kansas - Winfield | Recruiting |
Winfield, Kansas, United States, 67156 | |
Contact: Site Public Contact 316-268-5374 Keisha.humphries@ascension.org | |
Principal Investigator: Shaker R. Dakhil | |
United States, Kentucky | |
Flaget Memorial Hospital | Recruiting |
Bardstown, Kentucky, United States, 40004 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Jewish Hospital | Recruiting |
Louisville, Kentucky, United States, 40202 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Saints Mary and Elizabeth Hospital | Recruiting |
Louisville, Kentucky, United States, 40215 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Jewish Hospital Medical Center Northeast | Recruiting |
Louisville, Kentucky, United States, 40245 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
United States, Louisiana | |
Baton Rouge General Medical Center | Suspended |
Baton Rouge, Louisiana, United States, 70806 | |
Hematology/Oncology Clinic PLLC | Recruiting |
Baton Rouge, Louisiana, United States, 70809 | |
Contact: Site Public Contact 225-761-3951 Aimee.Alumbaugh@aoncology.com | |
Principal Investigator: Pedro M. Barata | |
Tulane University Health Sciences Center | Recruiting |
New Orleans, Louisiana, United States, 70112 | |
Contact: Site Public Contact 504-988-6121 | |
Principal Investigator: Pedro M. Barata | |
Ochsner Medical Center Jefferson | Active, not recruiting |
New Orleans, Louisiana, United States, 70121 | |
United States, Massachusetts | |
Lahey Hospital and Medical Center | Active, not recruiting |
Burlington, Massachusetts, United States, 01805 | |
United States, Michigan | |
Saint Joseph Mercy Hospital | Recruiting |
Ann Arbor, Michigan, United States, 48106 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Christopher M. Reynolds | |
University of Michigan Comprehensive Cancer Center | Active, not recruiting |
Ann Arbor, Michigan, United States, 48109 | |
Bronson Battle Creek | Recruiting |
Battle Creek, Michigan, United States, 49017 | |
Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
IHA Hematology Oncology Consultants-Brighton | Recruiting |
Brighton, Michigan, United States, 48114 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Christopher M. Reynolds | |
Saint Joseph Mercy Brighton | Recruiting |
Brighton, Michigan, United States, 48114 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Christopher M. Reynolds | |
Henry Ford Cancer Institute-Downriver | Recruiting |
Brownstown, Michigan, United States, 48183 | |
Contact: Site Public Contact 313-916-3721 CTOResearch@hfhs.org | |
Principal Investigator: Ding Wang | |
IHA Hematology Oncology Consultants-Canton | Recruiting |
Canton, Michigan, United States, 48188 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Christopher M. Reynolds | |
Saint Joseph Mercy Canton | Recruiting |
Canton, Michigan, United States, 48188 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Christopher M. Reynolds | |
IHA Hematology Oncology Consultants-Chelsea | Recruiting |
Chelsea, Michigan, United States, 48118 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Christopher M. Reynolds | |
Saint Joseph Mercy Chelsea | Recruiting |
Chelsea, Michigan, United States, 48118 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Christopher M. Reynolds | |
Henry Ford Macomb Hospital-Clinton Township | Recruiting |
Clinton Township, Michigan, United States, 48038 | |
Contact: Site Public Contact 313-916-3721 CTOResearch@hfhs.org | |
Principal Investigator: Ding Wang | |
Beaumont Hospital - Dearborn | Suspended |
Dearborn, Michigan, United States, 48124 | |
Henry Ford Medical Center-Fairlane | Recruiting |
Dearborn, Michigan, United States, 48126 | |
Contact: Site Public Contact 313-916-3721 CTOResearch@hfhs.org | |
Principal Investigator: Ding Wang | |
Henry Ford Hospital | Recruiting |
Detroit, Michigan, United States, 48202 | |
Contact: Site Public Contact 313-916-3721 CTOResearch@hfhs.org | |
Principal Investigator: Ding Wang | |
Ascension Saint John Hospital | Recruiting |
Detroit, Michigan, United States, 48236 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Christopher M. Reynolds | |
Great Lakes Cancer Management Specialists-Doctors Park | Recruiting |
East China Township, Michigan, United States, 48054 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Christopher M. Reynolds | |
Genesys Hurley Cancer Institute | Recruiting |
Flint, Michigan, United States, 48503 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Christopher M. Reynolds | |
Helen DeVos Children's Hospital at Spectrum Health | Recruiting |
Grand Rapids, Michigan, United States, 49503 | |
Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
Mercy Health Saint Mary's | Recruiting |
Grand Rapids, Michigan, United States, 49503 | |
Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
Spectrum Health at Butterworth Campus | Recruiting |
Grand Rapids, Michigan, United States, 49503 | |
Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
Academic Hematology Oncology Specialists | Recruiting |
Grosse Pointe Woods, Michigan, United States, 48236 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Christopher M. Reynolds | |
Great Lakes Cancer Management Specialists-Van Elslander Cancer Center | Recruiting |
Grosse Pointe Woods, Michigan, United States, 48236 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Christopher M. Reynolds | |
Michigan Breast Specialists-Grosse Pointe Woods | Recruiting |
Grosse Pointe Woods, Michigan, United States, 48236 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Christopher M. Reynolds | |
Allegiance Health | Recruiting |
Jackson, Michigan, United States, 49201 | |
Contact: Site Public Contact 313-916-3721 CTOResearch@hfhs.org | |
Principal Investigator: Ding Wang | |
West Michigan Cancer Center | Recruiting |
Kalamazoo, Michigan, United States, 49007 | |
Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
Sparrow Hospital | Recruiting |
Lansing, Michigan, United States, 48912 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Christopher M. Reynolds | |
Saint Mary Mercy Hospital | Recruiting |
Livonia, Michigan, United States, 48154 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Christopher M. Reynolds | |
Great Lakes Cancer Management Specialists-Macomb Medical Campus | Recruiting |
Macomb, Michigan, United States, 48044 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Christopher M. Reynolds | |
Michigan Breast Specialists-Macomb Township | Recruiting |
Macomb, Michigan, United States, 48044 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Christopher M. Reynolds | |
Mercy Health Mercy Campus | Recruiting |
Muskegon, Michigan, United States, 49444 | |
Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
Henry Ford Medical Center-Columbus | Recruiting |
Novi, Michigan, United States, 48377 | |
Contact: Site Public Contact 313-916-3721 CTOResearch@hfhs.org | |
Principal Investigator: Ding Wang | |
Saint Joseph Mercy Oakland | Recruiting |
Pontiac, Michigan, United States, 48341 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Christopher M. Reynolds | |
Lake Huron Medical Center | Suspended |
Port Huron, Michigan, United States, 48060 | |
Spectrum Health Reed City Hospital | Recruiting |
Reed City, Michigan, United States, 49677 | |
Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
Great Lakes Cancer Management Specialists-Rochester Hills | Suspended |
Rochester Hills, Michigan, United States, 48309 | |
Ascension Saint Mary's Hospital | Recruiting |
Saginaw, Michigan, United States, 48601 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Christopher M. Reynolds | |
Lakeland Medical Center Saint Joseph | Recruiting |
Saint Joseph, Michigan, United States, 49085 | |
Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
Marie Yeager Cancer Center | Recruiting |
Saint Joseph, Michigan, United States, 49085 | |
Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
Bhadresh Nayak MD PC-Sterling Heights | Recruiting |
Sterling Heights, Michigan, United States, 48312 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Christopher M. Reynolds | |
Munson Medical Center | Recruiting |
Traverse City, Michigan, United States, 49684 | |
Contact: Site Public Contact 616-391-1230 crcwm-regulatory@crcwm.org | |
Principal Investigator: Kathleen J. Yost | |
Advanced Breast Care Center PLLC | Recruiting |
Warren, Michigan, United States, 48088 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Christopher M. Reynolds | |
Great Lakes Cancer Management Specialists-Macomb Professional Building | Recruiting |
Warren, Michigan, United States, 48093 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Christopher M. Reynolds | |
Macomb Hematology Oncology PC | Recruiting |
Warren, Michigan, United States, 48093 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Christopher M. Reynolds | |
Michigan Breast Specialists-Warren | Recruiting |
Warren, Michigan, United States, 48093 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Christopher M. Reynolds | |
Saint John Macomb-Oakland Hospital | Recruiting |
Warren, Michigan, United States, 48093 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Christopher M. Reynolds | |
Henry Ford West Bloomfield Hospital | Recruiting |
West Bloomfield, Michigan, United States, 48322 | |
Contact: Site Public Contact 313-916-3721 CTOResearch@hfhs.org | |
Principal Investigator: Ding Wang | |
IHA Hematology Oncology Consultants-Ann Arbor | Recruiting |
Ypsilanti, Michigan, United States, 48197 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Christopher M. Reynolds | |
United States, Minnesota | |
Sanford Joe Lueken Cancer Center | Recruiting |
Bemidji, Minnesota, United States, 56601 | |
Contact: Site Public Contact 218-333-5000 OncologyClinicalTrialsFargo@sanfordhealth.org | |
Principal Investigator: Preston D. Steen | |
Fairview Ridges Hospital | Recruiting |
Burnsville, Minnesota, United States, 55337 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Mercy Hospital | Recruiting |
Coon Rapids, Minnesota, United States, 55433 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Essentia Health - Deer River Clinic | Recruiting |
Deer River, Minnesota, United States, 56636 | |
Contact: Site Public Contact 218-786-3308 CancerTrials@EssentiaHealth.org | |
Principal Investigator: Bret E. Friday | |
Essentia Health Cancer Center | Recruiting |
Duluth, Minnesota, United States, 55805 | |
Contact: Site Public Contact 218-786-3308 CancerTrials@EssentiaHealth.org | |
Principal Investigator: Bret E. Friday | |
Essentia Health Saint Mary's Medical Center | Recruiting |
Duluth, Minnesota, United States, 55805 | |
Contact: Site Public Contact 218-786-3308 CancerTrials@EssentiaHealth.org | |
Principal Investigator: Bret E. Friday | |
Miller-Dwan Hospital | Recruiting |
Duluth, Minnesota, United States, 55805 | |
Contact: Site Public Contact 218-786-3308 CancerTrials@EssentiaHealth.org | |
Principal Investigator: Bret E. Friday | |
Fairview Southdale Hospital | Recruiting |
Edina, Minnesota, United States, 55435 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Lake Region Healthcare Corporation-Cancer Care | Recruiting |
Fergus Falls, Minnesota, United States, 56537 | |
Contact: Site Public Contact 218-786-3308 CancerTrials@EssentiaHealth.org | |
Principal Investigator: Bret E. Friday | |
Unity Hospital | Recruiting |
Fridley, Minnesota, United States, 55432 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Essentia Health Hibbing Clinic | Recruiting |
Hibbing, Minnesota, United States, 55746 | |
Contact: Site Public Contact 218-786-3308 | |
Principal Investigator: Bret E. Friday | |
Minnesota Oncology Hematology PA-Maplewood | Recruiting |
Maplewood, Minnesota, United States, 55109 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Saint John's Hospital - Healtheast | Recruiting |
Maplewood, Minnesota, United States, 55109 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Abbott-Northwestern Hospital | Recruiting |
Minneapolis, Minnesota, United States, 55407 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Hennepin County Medical Center | Recruiting |
Minneapolis, Minnesota, United States, 55415 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Health Partners Inc | Recruiting |
Minneapolis, Minnesota, United States, 55454 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
North Memorial Medical Health Center | Recruiting |
Robbinsdale, Minnesota, United States, 55422 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Mayo Clinic in Rochester | Active, not recruiting |
Rochester, Minnesota, United States, 55905 | |
Coborn Cancer Center at Saint Cloud Hospital | Recruiting |
Saint Cloud, Minnesota, United States, 56303 | |
Contact: Site Public Contact 877-229-4907 coborncancercenter@centracare.com | |
Principal Investigator: Donald J. Jurgens | |
Park Nicollet Clinic - Saint Louis Park | Recruiting |
Saint Louis Park, Minnesota, United States, 55416 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Regions Hospital | Recruiting |
Saint Paul, Minnesota, United States, 55101 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
United Hospital | Recruiting |
Saint Paul, Minnesota, United States, 55102 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Essentia Health Sandstone | Recruiting |
Sandstone, Minnesota, United States, 55072 | |
Contact: Site Public Contact 218-786-3308 CancerTrials@EssentiaHealth.org | |
Principal Investigator: Bret E. Friday | |
Saint Francis Regional Medical Center | Recruiting |
Shakopee, Minnesota, United States, 55379 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Lakeview Hospital | Recruiting |
Stillwater, Minnesota, United States, 55082 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Essentia Health Virginia Clinic | Recruiting |
Virginia, Minnesota, United States, 55792 | |
Contact: Site Public Contact 218-786-3308 CancerTrials@EssentiaHealth.org | |
Principal Investigator: Bret E. Friday | |
Ridgeview Medical Center | Recruiting |
Waconia, Minnesota, United States, 55387 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Rice Memorial Hospital | Recruiting |
Willmar, Minnesota, United States, 56201 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Minnesota Oncology Hematology PA-Woodbury | Recruiting |
Woodbury, Minnesota, United States, 55125 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
United States, Missouri | |
Central Care Cancer Center - Bolivar | Suspended |
Bolivar, Missouri, United States, 65613 | |
Parkland Health Center-Bonne Terre | Suspended |
Bonne Terre, Missouri, United States, 63628 | |
Saint Francis Medical Center | Recruiting |
Cape Girardeau, Missouri, United States, 63703 | |
Contact: Site Public Contact 573-334-2230 sfmc@sfmc.net | |
Principal Investigator: Bryan A. Faller | |
Southeast Cancer Center | Recruiting |
Cape Girardeau, Missouri, United States, 63703 | |
Contact: Site Public Contact 573-651-5550 | |
Principal Investigator: Bryan A. Faller | |
Capital Region Southwest Campus | Recruiting |
Jefferson City, Missouri, United States, 65109 | |
Contact: Site Public Contact 573-632-4814 swooden@mail.crmc.org | |
Principal Investigator: Bryan A. Faller | |
Saint Luke's Hospital of Kansas City | Active, not recruiting |
Kansas City, Missouri, United States, 64111 | |
Kansas City Veterans Affairs Medical Center | Recruiting |
Kansas City, Missouri, United States, 64128 | |
Contact: Site Public Contact 800-525-1483 | |
Principal Investigator: Suman Kambhampati | |
Delbert Day Cancer Institute at PCRMC | Recruiting |
Rolla, Missouri, United States, 65401 | |
Contact: Site Public Contact 573-458-8776 kaysmith@phelpshealth.org | |
Principal Investigator: Jay W. Carlson | |
Mercy Clinic-Rolla-Cancer and Hematology | Recruiting |
Rolla, Missouri, United States, 65401 | |
Contact: Site Public Contact 573-458-6379 | |
Principal Investigator: Jay W. Carlson | |
Saint Louis Cancer and Breast Institute-South City | Recruiting |
Saint Louis, Missouri, United States, 63109 | |
Contact: Site Public Contact 314-353-1870 | |
Principal Investigator: Jay W. Carlson | |
Washington University School of Medicine | Recruiting |
Saint Louis, Missouri, United States, 63110 | |
Contact: Site Public Contact 800-600-3606 info@siteman.wustl.edu | |
Principal Investigator: Brad S. Kahl | |
Mercy Hospital South | Recruiting |
Saint Louis, Missouri, United States, 63128 | |
Contact: Site Public Contact janet.lesko@mercy.net | |
Principal Investigator: Jay W. Carlson | |
Missouri Baptist Medical Center | Recruiting |
Saint Louis, Missouri, United States, 63131 | |
Contact: Site Public Contact 314-996-5569 | |
Principal Investigator: Bryan A. Faller | |
Mercy Hospital Saint Louis | Recruiting |
Saint Louis, Missouri, United States, 63141 | |
Contact: Site Public Contact 314-251-7066 | |
Principal Investigator: Jay W. Carlson | |
Sainte Genevieve County Memorial Hospital | Recruiting |
Sainte Genevieve, Missouri, United States, 63670 | |
Contact: Site Public Contact 314-996-5569 | |
Principal Investigator: Bryan A. Faller | |
Mercy Hospital Springfield | Recruiting |
Springfield, Missouri, United States, 65804 | |
Contact: Site Public Contact 417-269-4520 | |
Principal Investigator: Jay W. Carlson | |
CoxHealth South Hospital | Recruiting |
Springfield, Missouri, United States, 65807 | |
Contact: Site Public Contact 417-269-4520 | |
Principal Investigator: Jay W. Carlson | |
Missouri Baptist Sullivan Hospital | Recruiting |
Sullivan, Missouri, United States, 63080 | |
Contact: Site Public Contact 314-996-5569 | |
Principal Investigator: Bryan A. Faller | |
Missouri Baptist Outpatient Center-Sunset Hills | Recruiting |
Sunset Hills, Missouri, United States, 63127 | |
Contact: Site Public Contact 314-996-5569 | |
Principal Investigator: Bryan A. Faller | |
United States, Montana | |
Billings Clinic Cancer Center | Recruiting |
Billings, Montana, United States, 59101 | |
Contact: Site Public Contact 800-996-2663 research@billingsclinic.org | |
Principal Investigator: John M. Schallenkamp | |
Bozeman Deaconess Hospital | Recruiting |
Bozeman, Montana, United States, 59715 | |
Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
Principal Investigator: John M. Schallenkamp | |
Saint James Community Hospital and Cancer Treatment Center | Suspended |
Butte, Montana, United States, 59701 | |
Benefis Healthcare- Sletten Cancer Institute | Recruiting |
Great Falls, Montana, United States, 59405 | |
Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
Principal Investigator: John M. Schallenkamp | |
Kalispell Regional Medical Center | Recruiting |
Kalispell, Montana, United States, 59901 | |
Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
Principal Investigator: John M. Schallenkamp | |
Saint Patrick Hospital - Community Hospital | Recruiting |
Missoula, Montana, United States, 59802 | |
Contact: Site Public Contact 406-327-3118 amy.hanneman@providence.org | |
Principal Investigator: Gary E. Goodman | |
Community Medical Hospital | Recruiting |
Missoula, Montana, United States, 59804 | |
Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
Principal Investigator: John M. Schallenkamp | |
United States, Nebraska | |
Nebraska Medicine-Bellevue | Recruiting |
Bellevue, Nebraska, United States, 68123 | |
Contact: Site Public Contact 402-559-6941 unmcrsa@unmc.edu | |
Principal Investigator: Matthew A. Lunning | |
CHI Health Saint Francis | Recruiting |
Grand Island, Nebraska, United States, 68803 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
CHI Health Good Samaritan | Recruiting |
Kearney, Nebraska, United States, 68847 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Nebraska Medicine-Village Pointe | Recruiting |
Omaha, Nebraska, United States, 68118 | |
Contact: Site Public Contact 402-559-5600 | |
Principal Investigator: Matthew A. Lunning | |
University of Nebraska Medical Center | Recruiting |
Omaha, Nebraska, United States, 68198 | |
Contact: Site Public Contact 402-559-6941 unmcrsa@unmc.edu | |
Principal Investigator: Matthew A. Lunning | |
United States, Nevada | |
Carson Tahoe Regional Medical Center | Recruiting |
Carson City, Nevada, United States, 89703 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Cancer and Blood Specialists-Henderson | Recruiting |
Henderson, Nevada, United States, 89052 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Comprehensive Cancer Centers of Nevada - Henderson | Recruiting |
Henderson, Nevada, United States, 89052 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Las Vegas Cancer Center-Henderson | Recruiting |
Henderson, Nevada, United States, 89052 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
21st Century Oncology-Henderson | Recruiting |
Henderson, Nevada, United States, 89074 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Comprehensive Cancer Centers of Nevada-Southeast Henderson | Recruiting |
Henderson, Nevada, United States, 89074 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
University Medical Center of Southern Nevada | Recruiting |
Las Vegas, Nevada, United States, 89102 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Cancer and Blood Specialists-Shadow | Suspended |
Las Vegas, Nevada, United States, 89106 | |
Radiation Oncology Centers of Nevada Central | Recruiting |
Las Vegas, Nevada, United States, 89106 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
21st Century Oncology | Recruiting |
Las Vegas, Nevada, United States, 89109 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
HealthCare Partners Medical Group Oncology/Hematology-Maryland Parkway | Suspended |
Las Vegas, Nevada, United States, 89109 | |
Sunrise Hospital and Medical Center | Recruiting |
Las Vegas, Nevada, United States, 89109 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
HealthCare Partners Medical Group Oncology/Hematology-San Martin | Suspended |
Las Vegas, Nevada, United States, 89113 | |
Radiation Oncology Centers of Nevada Southeast | Recruiting |
Las Vegas, Nevada, United States, 89119 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
21st Century Oncology-Vegas Tenaya | Recruiting |
Las Vegas, Nevada, United States, 89128 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Ann M Wierman MD LTD | Recruiting |
Las Vegas, Nevada, United States, 89128 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Comprehensive Cancer Centers of Nevada - Northwest | Recruiting |
Las Vegas, Nevada, United States, 89128 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
HealthCare Partners Medical Group Oncology/Hematology-Tenaya | Suspended |
Las Vegas, Nevada, United States, 89128 | |
Alliance for Childhood Diseases/Cure 4 the Kids Foundation | Recruiting |
Las Vegas, Nevada, United States, 89135 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Comprehensive Cancer Centers of Nevada-Summerlin | Recruiting |
Las Vegas, Nevada, United States, 89144 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Summerlin Hospital Medical Center | Recruiting |
Las Vegas, Nevada, United States, 89144 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Las Vegas Cancer Center-Medical Center | Recruiting |
Las Vegas, Nevada, United States, 89148-2405 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
21st Century Oncology-Fort Apache | Recruiting |
Las Vegas, Nevada, United States, 89148 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Comprehensive Cancer Centers of Nevada | Recruiting |
Las Vegas, Nevada, United States, 89148 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
OptumCare Cancer Care at Fort Apache | Recruiting |
Las Vegas, Nevada, United States, 89148 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
HealthCare Partners Medical Group Oncology/Hematology-Centennial Hills | Suspended |
Las Vegas, Nevada, United States, 89149 | |
Comprehensive Cancer Centers of Nevada - Central Valley | Recruiting |
Las Vegas, Nevada, United States, 89169 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
University Cancer Center | Recruiting |
Las Vegas, Nevada, United States, 89169 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Renown Regional Medical Center | Recruiting |
Reno, Nevada, United States, 89502 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
Saint Mary's Regional Medical Center | Recruiting |
Reno, Nevada, United States, 89503 | |
Contact: Site Public Contact 702-384-0013 research@sncrf.org | |
Principal Investigator: John A. Ellerton | |
United States, New Hampshire | |
Dartmouth Hitchcock Medical Center | Recruiting |
Lebanon, New Hampshire, United States, 03756 | |
Contact: Site Public Contact 800-639-6918 cancer.research.nurse@dartmouth.edu | |
Principal Investigator: Frederick Lansigan | |
United States, New Mexico | |
University of New Mexico Cancer Center | Active, not recruiting |
Albuquerque, New Mexico, United States, 87102 | |
United States, New York | |
Roswell Park Cancer Institute | Recruiting |
Buffalo, New York, United States, 14263 | |
Contact: Site Public Contact 800-767-9355 askroswell@roswellpark.org | |
Principal Investigator: Suchitra Sundaram | |
Northwell Health/Center for Advanced Medicine | Recruiting |
Lake Success, New York, United States, 11042 | |
Contact: Site Public Contact 516-734-8896 | |
Principal Investigator: Sadia Riaz | |
North Shore University Hospital | Recruiting |
Manhasset, New York, United States, 11030 | |
Contact: Site Public Contact 516-734-8896 | |
Principal Investigator: Sadia Riaz | |
Long Island Jewish Medical Center | Recruiting |
New Hyde Park, New York, United States, 11040 | |
Contact: Site Public Contact 516-734-8896 | |
Principal Investigator: Sadia Riaz | |
NYP/Weill Cornell Medical Center | Active, not recruiting |
New York, New York, United States, 10065 | |
University of Rochester | Recruiting |
Rochester, New York, United States, 14642 | |
Contact: Site Public Contact 585-275-5830 | |
Principal Investigator: Paul M. Barr | |
United States, North Carolina | |
Carolinas Medical Center/Levine Cancer Institute | Active, not recruiting |
Charlotte, North Carolina, United States, 28203 | |
Southeastern Medical Oncology Center-Clinton | Recruiting |
Clinton, North Carolina, United States, 28328 | |
Contact: Site Public Contact 919-587-9084 jfields@cancersmoc.com | |
Principal Investigator: Samer S. Kasbari | |
Southeastern Medical Oncology Center-Goldsboro | Recruiting |
Goldsboro, North Carolina, United States, 27534 | |
Contact: Site Public Contact 919-587-9084 jfields@cancersmoc.com | |
Principal Investigator: Samer S. Kasbari | |
Wayne Memorial Hospital | Active, not recruiting |
Goldsboro, North Carolina, United States, 27534 | |
Margaret R Pardee Memorial Hospital | Recruiting |
Hendersonville, North Carolina, United States, 28791 | |
Contact: Site Public Contact 828-696-4716 karen.morris@unchealth.unc.edu | |
Principal Investigator: James E. Radford | |
Southeastern Medical Oncology Center-Jacksonville | Recruiting |
Jacksonville, North Carolina, United States, 28546 | |
Contact: Site Public Contact 910-587-9084 jfields@cancersmoc.com | |
Principal Investigator: Samer S. Kasbari | |
United States, North Dakota | |
Sanford Bismarck Medical Center | Recruiting |
Bismarck, North Dakota, United States, 58501 | |
Contact: Site Public Contact 701-323-5760 OncologyClinicalTrialsFargo@sanfordhealth.org | |
Principal Investigator: Preston D. Steen | |
Sanford Broadway Medical Center | Recruiting |
Fargo, North Dakota, United States, 58122 | |
Contact: Site Public Contact 701-323-5760 OncologyClinicalTrialsFargo@sanfordhealth.org | |
Principal Investigator: Preston D. Steen | |
Sanford Roger Maris Cancer Center | Recruiting |
Fargo, North Dakota, United States, 58122 | |
Contact: Site Public Contact 701-234-6161 OncologyClinicalTrialsFargo@sanfordhealth.org | |
Principal Investigator: Preston D. Steen | |
United States, Ohio | |
Good Samaritan Hospital - Cincinnati | Recruiting |
Cincinnati, Ohio, United States, 45220 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
TriHealth Cancer Institute-Westside | Recruiting |
Cincinnati, Ohio, United States, 45247 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
TriHealth Cancer Institute-Anderson | Recruiting |
Cincinnati, Ohio, United States, 45255 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
MetroHealth Medical Center | Recruiting |
Cleveland, Ohio, United States, 44109 | |
Contact: Site Public Contact 216-778-8526 dstrater@metrohealth.org | |
Principal Investigator: William Tse | |
Ohio State University Comprehensive Cancer Center | Recruiting |
Columbus, Ohio, United States, 43210 | |
Contact: Site Public Contact 800-293-5066 Jamesline@osumc.edu | |
Principal Investigator: Kami J. Maddocks | |
Mount Carmel East Hospital | Recruiting |
Columbus, Ohio, United States, 43213 | |
Contact: Site Public Contact 614-488-2118 sheree@columbusccop.org | |
Principal Investigator: Timothy D. Moore | |
Columbus Oncology and Hematology Associates Inc | Recruiting |
Columbus, Ohio, United States, 43214 | |
Contact: Site Public Contact 614-488-2118 sheree@columbusccop.org | |
Principal Investigator: Timothy D. Moore | |
Riverside Methodist Hospital | Recruiting |
Columbus, Ohio, United States, 43214 | |
Contact: Site Public Contact 614-566-4475 sheree@columbusccop.org | |
Principal Investigator: Timothy D. Moore | |
The Mark H Zangmeister Center | Recruiting |
Columbus, Ohio, United States, 43219 | |
Contact: Site Public Contact 614-488-2118 sheree@columbusccop.org | |
Principal Investigator: Timothy D. Moore | |
Mount Carmel Health Center West | Recruiting |
Columbus, Ohio, United States, 43222 | |
Contact: Site Public Contact 614-234-5433 sheree@columbusccop.org | |
Principal Investigator: Timothy D. Moore | |
Good Samaritan Hospital - Dayton | Suspended |
Dayton, Ohio, United States, 45406 | |
Miami Valley Hospital | Recruiting |
Dayton, Ohio, United States, 45409 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
Miami Valley Hospital North | Recruiting |
Dayton, Ohio, United States, 45415 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
Blanchard Valley Hospital | Recruiting |
Findlay, Ohio, United States, 45840 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
Marietta Memorial Hospital | Recruiting |
Marietta, Ohio, United States, 45750 | |
Contact: Site Public Contact 800-523-3977 sheree@columbusccop.org | |
Principal Investigator: Timothy D. Moore | |
Toledo Clinic Cancer Centers-Maumee | Active, not recruiting |
Maumee, Ohio, United States, 43537 | |
Licking Memorial Hospital | Recruiting |
Newark, Ohio, United States, 43055 | |
Contact: Site Public Contact 740-348-4000 sheree@columbusccop.org | |
Principal Investigator: Timothy D. Moore | |
Springfield Regional Cancer Center | Recruiting |
Springfield, Ohio, United States, 45504 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
Springfield Regional Medical Center | Recruiting |
Springfield, Ohio, United States, 45505 | |
Contact: Site Public Contact 937-528-2900 clinical.trials@daytonncorp.org | |
Principal Investigator: Howard M. Gross | |
Toledo Clinic Cancer Centers-Toledo | Recruiting |
Toledo, Ohio, United States, 43623 | |
Contact: Site Public Contact 800-444-3561 | |
Principal Investigator: Rex B. Mowat | |
Saint Ann's Hospital | Recruiting |
Westerville, Ohio, United States, 43081 | |
Contact: Site Public Contact 614-234-5433 sheree@columbusccop.org | |
Principal Investigator: Timothy D. Moore | |
United States, Oklahoma | |
University of Oklahoma Health Sciences Center | Recruiting |
Oklahoma City, Oklahoma, United States, 73104 | |
Contact: Site Public Contact 405-271-8777 ou-clinical-trials@ouhsc.edu | |
Principal Investigator: George B. Selby | |
United States, Oregon | |
Clackamas Radiation Oncology Center | Recruiting |
Clackamas, Oregon, United States, 97015 | |
Contact: Site Public Contact 503-215-2614 CanRsrchStudies@providence.org | |
Principal Investigator: Gary E. Goodman | |
Providence Cancer Institute Clackamas Clinic | Recruiting |
Clackamas, Oregon, United States, 97015 | |
Contact: Site Public Contact 503-215-2614 CanRsrchStudies@providence.org | |
Principal Investigator: Gary E. Goodman | |
Bay Area Hospital | Recruiting |
Coos Bay, Oregon, United States, 97420 | |
Contact: Site Public Contact 541-269-8392 cherie.cox@bayareahospital.org | |
Principal Investigator: Gary E. Goodman | |
Providence Newberg Medical Center | Recruiting |
Newberg, Oregon, United States, 97132 | |
Contact: Site Public Contact 503-215-2614 CanRsrchStudies@providence.org | |
Principal Investigator: Gary E. Goodman | |
Providence Portland Medical Center | Recruiting |
Portland, Oregon, United States, 97213 | |
Contact: Site Public Contact 503-215-2614 CanRsrchStudies@providence.org | |
Principal Investigator: Gary E. Goodman | |
Providence Saint Vincent Medical Center | Recruiting |
Portland, Oregon, United States, 97225 | |
Contact: Site Public Contact 503-215-2614 CanRsrchStudies@providence.org | |
Principal Investigator: Gary E. Goodman | |
United States, Pennsylvania | |
Lehigh Valley Hospital-Cedar Crest | Recruiting |
Allentown, Pennsylvania, United States, 18103 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Christopher M. Reynolds | |
Bryn Mawr Hospital | Recruiting |
Bryn Mawr, Pennsylvania, United States, 19010 | |
Contact: Site Public Contact 484-476-2649 turzoe@mlhs.org | |
Principal Investigator: Albert S. DeNittis | |
Main Line Health Center-Collegeville | Recruiting |
Collegeville, Pennsylvania, United States, 19426 | |
Contact: Site Public Contact 484-476-2649 turzoe@mlhs.org | |
Principal Investigator: Albert S. DeNittis | |
Geisinger Medical Center | Recruiting |
Danville, Pennsylvania, United States, 17822 | |
Contact: Site Public Contact 570-271-5251 HemonCCTrials@geisinger.edu | |
Principal Investigator: Joseph J. Vadakara | |
Main Line Health Center-Exton | Recruiting |
Exton, Pennsylvania, United States, 19341 | |
Contact: Site Public Contact 484-476-2649 turzoe@mlhs.org | |
Principal Investigator: Albert S. DeNittis | |
Geisinger Medical Center-Cancer Center Hazleton | Recruiting |
Hazleton, Pennsylvania, United States, 18201 | |
Contact: Site Public Contact 570-459-2901 HemonCCTrials@geisinger.edu | |
Principal Investigator: Joseph J. Vadakara | |
Geisinger Medical Oncology-Lewisburg | Recruiting |
Lewisburg, Pennsylvania, United States, 17837 | |
Contact: Site Public Contact 570-374-8555 HemonCCTrials@geisinger.edu | |
Principal Investigator: Joseph J. Vadakara | |
Riddle Memorial Hospital | Recruiting |
Media, Pennsylvania, United States, 19063 | |
Contact: Site Public Contact 484-476-2649 turzoe@mlhs.org | |
Principal Investigator: Albert S. DeNittis | |
Paoli Memorial Hospital | Recruiting |
Paoli, Pennsylvania, United States, 19301 | |
Contact: Site Public Contact 484-476-2649 turzoe@mlhs.org | |
Principal Investigator: Albert S. DeNittis | |
Geisinger Cancer Services-Pottsville | Recruiting |
Pottsville, Pennsylvania, United States, 17901 | |
Contact: Site Public Contact 800-275-6401 HemonCCTrials@geisinger.edu | |
Principal Investigator: Joseph J. Vadakara | |
Geisinger Medical Oncology-Selinsgrove | Recruiting |
Selinsgrove, Pennsylvania, United States, 17870 | |
Contact: Site Public Contact 570-374-8555 HemonCCTrials@geisinger.edu | |
Principal Investigator: Joseph J. Vadakara | |
Reading Hospital | Recruiting |
West Reading, Pennsylvania, United States, 19611 | |
Contact: Site Public Contact 610-988-9323 | |
Principal Investigator: Terrence P. Cescon | |
Geisinger Wyoming Valley/Henry Cancer Center | Recruiting |
Wilkes-Barre, Pennsylvania, United States, 18711 | |
Contact: Site Public Contact 570-271-5251 HemonCCTrials@geisinger.edu | |
Principal Investigator: Joseph J. Vadakara | |
Lankenau Medical Center | Recruiting |
Wynnewood, Pennsylvania, United States, 19096 | |
Contact: Site Public Contact 484-476-2649 turzoe@mlhs.org | |
Principal Investigator: Albert S. DeNittis | |
United States, South Carolina | |
Medical University of South Carolina | Recruiting |
Charleston, South Carolina, United States, 29425 | |
Contact: Site Public Contact 843-792-9321 hcc-clinical-trials@musc.edu | |
Principal Investigator: Brian T. Hess | |
Saint Francis Hospital | Recruiting |
Greenville, South Carolina, United States, 29601 | |
Contact: Site Public Contact 864-603-6213 melissa_beckman@bshsi.org | |
Principal Investigator: Howland E. Crosswell | |
Saint Francis Cancer Center | Recruiting |
Greenville, South Carolina, United States, 29607 | |
Contact: Site Public Contact 864-603-6213 melissa_beckman@bshsi.org | |
Principal Investigator: Howland E. Crosswell | |
Self Regional Healthcare | Active, not recruiting |
Greenwood, South Carolina, United States, 29646 | |
Spartanburg Medical Center | Active, not recruiting |
Spartanburg, South Carolina, United States, 29303 | |
United States, South Dakota | |
Sanford Cancer Center Oncology Clinic | Recruiting |
Sioux Falls, South Dakota, United States, 57104 | |
Contact: Site Public Contact 605-312-3320 OncologyClinicTrialsSF@sanfordhealth.org | |
Principal Investigator: Preston D. Steen | |
Sanford USD Medical Center - Sioux Falls | Recruiting |
Sioux Falls, South Dakota, United States, 57117-5134 | |
Contact: Site Public Contact 605-312-3320 OncologyClinicalTrialsSF@SanfordHealth.org | |
Principal Investigator: Preston D. Steen | |
United States, Texas | |
M D Anderson Cancer Center | Recruiting |
Houston, Texas, United States, 77030 | |
Contact: Site Public Contact 877-632-6789 askmdanderson@mdanderson.org | |
Principal Investigator: Loretta J. Nastoupil | |
United States, Utah | |
Huntsman Cancer Institute/University of Utah | Recruiting |
Salt Lake City, Utah, United States, 84112 | |
Contact: Site Public Contact 888-424-2100 cancerinfo@hci.utah.edu | |
Principal Investigator: Deborah M. Stephens | |
United States, Washington | |
Swedish Cancer Institute-Edmonds | Recruiting |
Edmonds, Washington, United States, 98026 | |
Contact: Site Public Contact 206-215-3086 PCRC-NCORP@Swedish.org | |
Principal Investigator: Gary E. Goodman | |
PeaceHealth Saint John Medical Center | Recruiting |
Longview, Washington, United States, 98632 | |
Contact: Site Public Contact 360-514-2016 kmakin-bond@peacehealth.org | |
Principal Investigator: Gary E. Goodman | |
MultiCare Good Samaritan Hospital | Suspended |
Puyallup, Washington, United States, 98372 | |
Swedish Medical Center-Ballard Campus | Recruiting |
Seattle, Washington, United States, 98107 | |
Contact: Site Public Contact 206-215-3086 PCRC-NCORP@Swedish.org | |
Principal Investigator: Gary E. Goodman | |
Fred Hutchinson Cancer Research Center | Recruiting |
Seattle, Washington, United States, 98109 | |
Contact: Site Public Contact 800-804-8824 | |
Principal Investigator: Mazyar Shadman | |
Seattle Cancer Care Alliance | Recruiting |
Seattle, Washington, United States, 98109 | |
Contact: Site Public Contact 800-804-8824 | |
Principal Investigator: Mazyar Shadman | |
Swedish Medical Center-First Hill | Recruiting |
Seattle, Washington, United States, 98122-4307 | |
Contact: Site Public Contact 206-215-3086 PCRC-NCORP@Swedish.org | |
Principal Investigator: Gary E. Goodman | |
PeaceHealth Southwest Medical Center | Recruiting |
Vancouver, Washington, United States, 98664 | |
Contact: Site Public Contact 360-514-3940 kmakin-bond@peacehealth.org | |
Principal Investigator: Gary E. Goodman | |
United States, West Virginia | |
West Virginia University Charleston Division | Recruiting |
Charleston, West Virginia, United States, 25304 | |
Contact: Site Public Contact 304-388-9944 | |
Principal Investigator: Steven J. Jubelirer | |
United States, Wisconsin | |
Duluth Clinic Ashland | Recruiting |
Ashland, Wisconsin, United States, 54806 | |
Contact: Site Public Contact 218-786-3308 CancerTrials@EssentiaHealth.org | |
Principal Investigator: Bret E. Friday | |
Northwest Wisconsin Cancer Center | Recruiting |
Ashland, Wisconsin, United States, 54806 | |
Contact: Site Public Contact 218-786-3308 CancerTrials@EssentiaHealth.org | |
Principal Investigator: Bret E. Friday | |
Marshfield Clinic-Chippewa Center | Recruiting |
Chippewa Falls, Wisconsin, United States, 54729 | |
Contact: Site Public Contact 800-782-8581 oncology.clinical.trials@marshfieldresearch.org | |
Principal Investigator: Bilal H. Naqvi | |
Gundersen Lutheran Medical Center | Recruiting |
La Crosse, Wisconsin, United States, 54601 | |
Contact: Site Public Contact 608-775-2385 cancerctr@gundersenhealth.org | |
Principal Investigator: David E. Marinier | |
Marshfield Clinic - Ladysmith Center | Recruiting |
Ladysmith, Wisconsin, United States, 54848 | |
Contact: Site Public Contact 800-782-8581 oncology.clinical.trials@marshfieldresearch.org | |
Principal Investigator: Bilal H. Naqvi | |
University of Wisconsin Hospital and Clinics | Recruiting |
Madison, Wisconsin, United States, 53792 | |
Contact: Site Public Contact 800-622-8922 | |
Principal Investigator: Vaishalee P. Kenkre | |
Marshfield Medical Center-Marshfield | Recruiting |
Marshfield, Wisconsin, United States, 54449 | |
Contact: Site Public Contact 800-782-8581 oncology.clinical.trials@marshfieldresearch.org | |
Principal Investigator: Bilal H. Naqvi | |
Medical College of Wisconsin | Recruiting |
Milwaukee, Wisconsin, United States, 53226 | |
Contact: Site Public Contact 414-805-3666 | |
Principal Investigator: Timothy S. Fenske | |
Marshfield Clinic-Minocqua Center | Recruiting |
Minocqua, Wisconsin, United States, 54548 | |
Contact: Site Public Contact 800-782-8581 oncology.clinical.trials@marshfieldresearch.org | |
Principal Investigator: Bilal H. Naqvi | |
Cancer Center of Western Wisconsin | Recruiting |
New Richmond, Wisconsin, United States, 54017 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Marshfield Medical Center-Rice Lake | Recruiting |
Rice Lake, Wisconsin, United States, 54868 | |
Contact: Site Public Contact 800-782-8581 oncology.clinical.trials@marshfieldresearch.org | |
Principal Investigator: Bilal H. Naqvi | |
Marshfield Clinic-Wausau Center | Recruiting |
Wausau, Wisconsin, United States, 54401 | |
Contact: Site Public Contact 800-782-8581 oncology.clinical.trials@marshfieldresearch.org | |
Principal Investigator: Bilal H. Naqvi | |
Marshfield Medical Center - Weston | Recruiting |
Weston, Wisconsin, United States, 54476 | |
Contact: Site Public Contact 800-782-8581 oncology.clinical.trials@marshfieldresearch.org | |
Principal Investigator: Bilal H. Naqvi | |
Marshfield Clinic - Wisconsin Rapids Center | Recruiting |
Wisconsin Rapids, Wisconsin, United States, 54494 | |
Contact: Site Public Contact 800-782-8581 oncology.clinical.trials@marshfieldresearch.org | |
Principal Investigator: Bilal H. Naqvi |
Principal Investigator: | Paul M Barr | Southwest Oncology Group |
Responsible Party: | National Cancer Institute (NCI) |
ClinicalTrials.gov Identifier: | NCT03269669 |
Other Study ID Numbers: |
NCI-2017-00009 NCI-2017-00009 ( Registry Identifier: CTRP (Clinical Trial Reporting Program) ) S1608 ( Other Identifier: SWOG ) S1608 ( Other Identifier: CTEP ) U10CA180888 ( U.S. NIH Grant/Contract ) |
First Posted: | September 1, 2017 Key Record Dates |
Last Update Posted: | April 19, 2021 |
Last Verified: | January 2021 |
Studies a U.S. FDA-regulated Drug Product: | Yes |
Studies a U.S. FDA-regulated Device Product: | No |
Lymphoma Lymphoma, Follicular Neoplasms by Histologic Type Neoplasms Lymphoproliferative Disorders Lymphatic Diseases Immunoproliferative Disorders Immune System Diseases Lymphoma, Non-Hodgkin Prednisone Cortisone Cyclophosphamide Bendamustine Hydrochloride Doxorubicin Liposomal doxorubicin |
Vincristine Lenalidomide Obinutuzumab Immunosuppressive Agents Immunologic Factors Physiological Effects of Drugs Antirheumatic Agents Antineoplastic Agents, Alkylating Alkylating Agents Molecular Mechanisms of Pharmacological Action Antineoplastic Agents Myeloablative Agonists Antibiotics, Antineoplastic Topoisomerase II Inhibitors Topoisomerase Inhibitors |